在怀孕期间接种疫苗的促进因素和障碍:定性系统审查
Mohammad S Razai1, Rania Mansour1, Pahalavi Ravindran2
1Population Health Research Institute, St George's, University of London, London, United Kingdom.
PloS one
|April 19, 2024
概括
怀孕期间接种疫苗,包括流感,百日咳和COVID-19的疫苗,由于安全问题和缺乏知识,接种率很低. 医疗保健提供者的建议和明确的沟通是提高孕妇接种疫苗的关键.
科学领域:
- 孕产妇和儿童的健康
- 疫苗学 疫苗学 疫苗学
- 公共卫生 公共卫生
背景情况:
- 怀孕期间接种疫苗对于保护母亲和胎儿免受可预防的疾病至关重要.
- 在欧洲和美国的孕妇中,接种流感,百日咳和COVID-19等推疫苗的比例仍然很低.
- 了解障碍物和促进因素对于制定提高疫苗接种率的战略至关重要.
研究的目的:
- 确定在怀孕期间接种流感,百日咳和COVID-19疫苗的障碍和促进因素.
- 探索提高孕妇疫苗接种率的策略.
- 综合关于母婴疫苗接种的定性研究的发现.
主要方法:
- 2012-2022年在高收入国家发表的研究的定性系统审查.
- 在多个电子数据库和灰色文献中进行全面搜索.
- 使用Joanna Briggs研究所的批判性评估工具进行主题分析和质量评估.
主要成果:
- 包括28项涉及1573名参与者的研究.
- 主要障碍:对疫苗安全性/有效性的担忧,缺乏知识,害怕不良反应,以及低估疾病严重程度.
- 关键促进者:医疗保健提供者的建议,可访问性,清晰的沟通和社会支持.
结论:
- 需要采取干预措施,以解决在孕妇中发现的疫苗接种障碍.
- 强有力的医疗保健提供者建议,明确的风险/益处沟通和方便的访问是重要的促进因素.
- 解决安全问题和提供准确的疫苗信息对于改善接种是必不可少的.
相关概念视频
Barriers to Effective Communication II
3.6K
The barriers to effective communication also include cultural barriers, semantic barriers, gender barriers, and time constraints.
Cultural barriers:
Differences in values, beliefs, religion, knowledge, and tradition can significantly impact communication. Awareness of nonverbal cues is critical, especially when conversing with a patient from a different culture. What appears appropriate in one culture may be inappropriate in another.
Semantic barriers:
As a result of their tendency to use...
Cultural barriers:
Differences in values, beliefs, religion, knowledge, and tradition can significantly impact communication. Awareness of nonverbal cues is critical, especially when conversing with a patient from a different culture. What appears appropriate in one culture may be inappropriate in another.
Semantic barriers:
As a result of their tendency to use...
3.6K
Vaccinations
44.4K
Overview
44.4K
Physiological Barriers
3.5K
Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
3.5K
Development of Immunocompetence
305
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
305
Factors Affecting Drug Distribution: Physiological Barriers
197
Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
197
Teratogenicity
2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K


